NEW YORK Sept. 13 2011 PRNewswire IMMUNE Pharmaceuticals an emerging leader in the development of Antibody based Therapeutics for the treatment of inflammatory diseases and cancer today announced the appointment of Dr. Alan Harris M.D. Ph.D. to the positi...
↧